Medplus Health Services logo

Medplus Health Services financials and balance sheet

NSE: MEDPLUSBSE: 543427RetailingSmall Cap

Last close ₹595.15up ₹0.45 (0.08%)BSE ₹593.75

Share price at the NSE close on 23 Oct 2026. Previous close ₹594.70.

52-week range of traded prices to 23 Oct 2026
₹576.30Low, 23 Oct 2026₹1,022.20High, 21 May 2026
Market cap
₹7,150 Cr555th largest listed
P/E
34.0
P/B
3.6
Dividend yield
Nonein the last 12 months
ROE
11.3%
ROCE
15.9%
Debt to equity
0.00
Volume, NSE
1,18,62749.9% delivered

5 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Medplus Health Services annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹6,892 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue6,892
  2. Materials and goods−5,085
  3. Employee costs−885
  4. Other expenses−316
  5. Operating profit607
  6. Depreciation−283
  7. Other income+71
  8. One-off items0.0
  9. Finance costs−120
  10. Profit before tax275
  11. Tax−56
  12. Net profit220

What the company owns

  • Plant, investments and other assets₹2,062 Cr
  • Inventory₹1,382 Cr
  • Cash and bank₹462 Cr
  • Receivables₹27 Cr

What pays for it: net worth and liabilities

  • Net worth₹1,975 Cr
  • Other liabilities₹1,651 Cr
  • Owed to suppliers₹307 Cr

Medplus Health Services business segments, year to Mar 2026

A reportable segment is a line of business the company must report on its own. Consolidated, ₹ crore, as the company reports them.Medplus Health Services segment results by quarter

Revenue by segment

₹6,892 CrTotal
  • Retail₹6,760 Cr98.1% of total
  • Diagnostic services₹131 Cr1.9% of total
  • Others₹1 Cr0.0% of total

Profit by segment

  • Retail₹239 Cr99.0% of total
  • Diagnostic services₹2 Cr0.7% of total
  • Others₹1 Cr0.3% of total

Segment results by year

Consolidated, ₹ crore, years to March.

  • Retail

    Revenue, ₹ crore
    Profit, ₹ crore
  • Diagnostic services

    Revenue, ₹ crore
    Profit, ₹ crore
  • Others

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue of all businesses3,7794,5585,6256,1366,892
Company revenue, as in its results3,7794,5585,6256,1366,892
Revenue3,7594,5275,5496,0276,760
Revenue growth–20.4%22.6%8.6%12.2%
Profit1826092176239
Profit growth–−67.1%52.9%92.1%35.7%
Margin4.8%1.3%1.7%2.9%3.5%
Return on capital24.1%5.5%7.1%15.0%19.1%
Assets1,8862,3032,6172,6993,110
Liabilities1,1311,2121,3311,5291,857
Capital employed7541,0911,2861,1711,253
Revenue–3175108131
Revenue–0111
Revenue13––––
Revenue7––––
–––0–
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Consolidated, ₹ crore, years to March.Medplus Health Services quarterly results

₹ croreMar 2022Filed 13 JunMar 2023Filed 26 MayMar 2024Filed 29 MayMar 2025Filed 12 JunMar 2026Filed 20 May
Revenue from operations3,7794,5585,6256,1366,892
3,5074,2925,2715,6496,285
Materials and goods bought2,9823,5584,3924,6415,085
Employee costs394545626726885
Other expenses131189254282316
Operating profit before depreciation272266354487607
Operating margin7.2%5.8%6.3%7.9%8.8%
Materials, % of revenue78.9%78.1%78.1%75.6%73.8%
Employee costs, % of revenue10.4%12.0%11.1%11.8%12.8%
Other expenses, % of revenue3.5%4.1%4.5%4.6%4.6%
Depreciation and amortisation119182224250283
Operating profit after depreciation15384130237324
Other income3146404971
Finance costs668396103120
One-off items00000
Profit before tax1184773183275
23−383356
955066150220
Other comprehensive income20002
Total comprehensive income975066150222
Net margin2.5%1.1%1.2%2.4%3.2%

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2022Filed 13 JunMar 2023Filed 26 MayMar 2024Filed 29 MayMar 2025Filed 12 JunMar 2026Filed 20 May
1,4171,4911,5771,7401,975
1,4181,4911,5781,7411,975
Share capital2424242424
Reserves1,3941,4671,5541,7171,951
Belonging to outside owners of subsidiaries−1−1−1−1−1
Borrowings1430000
559477526577689
6188309021,0441,269
Total assets2,5942,7973,0053,3603,933
9621,3161,4371,5171,864
1,6321,4811,5681,8442,069
Net debt108−284−142−367−462
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2022Filed 13 JunMar 2023Filed 26 MayMar 2024Filed 29 MayMar 2025Filed 12 JunMar 2026Filed 20 May
17090144540496
203104173586613
−90−216−23173−64
Receivables000−90
Inventories−165−229−196−5−37
Payables000620
Other working capital7514−3525−27
Tax paid−34−14−29−45−74
Capital spending1181698459123
Free cash flow52−7959481373
−703429−83−318−128
440−170−198−228−256
Dividends paid00000
Shares bought back00000
Shares issued5940000
Net change in cash−93350−137−5112
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2022Filed 13 JunMar 2023Filed 26 MayMar 2024Filed 29 MayMar 2025Filed 12 JunMar 2026Filed 20 May
Earnings per share₹8.55₹4.17₹5.48₹12.57₹18.33
Diluted earnings per share₹8.52₹4.17₹5.45₹12.52₹18.29
Book value per share₹118.84₹124.99₹132.01₹145.42₹164.54
Shareholder yield−4.9%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)12,1047,7518,2109,08610,064

Ratios

Consolidated, years to March.Medplus Health Services PE ratio and valuation

RatioMar 2022Filed 13 JunMar 2023Filed 26 MayMar 2024Filed 29 MayMar 2025Filed 12 JunMar 2026Filed 20 May
Revenue growth–20.6%23.4%9.1%12.3%
Operating profit growth–−2.5%33.3%37.6%24.7%
Net profit growth–−47.1%30.9%129.1%46.2%
Earnings per share growth–−51.2%31.4%129.4%45.8%
6.8%3.4%4.3%9.1%11.8%
–−3.3 pts0.8 pts4.8 pts2.8 pts
From the net margin–−3.8 pts0.2 pts4.7 pts2.7 pts
From asset turnover–0.5 pts0.5 pts−0.1 pts−0.2 pts
From borrowing–0.0 pts0.1 pts0.1 pts0.3 pts
Return on capital employed9.8%5.6%8.2%13.6%16.4%
Cash conversion179.4%180.4%219.2%359.7%225.7%
Interest cover2.31.01.32.32.7
Debt to equity0.100.000.000.000.00
Receivable days11111
Inventory days11211711110699
Payable days3027212422
Cash conversion cycle, days8291918379
Working capital days11458585449
Asset turnover1.461.691.941.931.89
Assets per rupee of net worth1.831.851.891.921.96
Sales per rupee of plant23.3515.8117.6621.1121.65
Capital spending to depreciation0.990.930.380.240.43
Plant being built, % of plant in use12.6%8.3%1.7%4.5%10.0%

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
6.0%
Cash from operations against operating profit
81.6%
Measure5 years3 years
Revenue growth, yearly rate–14.8%
Profit growth, yearly rate–64.0%
Return on equity, average7.1%8.4%
Return on capital employed, average10.8%12.8%
Operating margin, average7.2%7.7%
Net margin, average2.1%2.3%
Asset turnover, average1.781.92
Cash conversion cycle, days, average8584
Interest cover, average1.92.1
Debt to equity, average0.020.00

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations1,4401,180496
Cash from investing−802−528−128
Cash from financing−411−682−256
Capital spending554267123
Dividends paid000
Shares bought back000
Shares issued for cash59400
Borrowings raised000
Borrowings repaid000

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––576
Altman Z-scorePublished threshold 1.819.116.516.656.646.29
Beneish M-scorePublished threshold −1.78–−2.03−1.81−3.30−1.98
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–−17.430.16−2.28−4.07
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––1.922.912.71
Receivables growth less revenue growthOur threshold 0 percentage points–22.7378.92−33.2790.81
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–5.75−6.30−5.31−6.85
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–−13.870.430.811.16
Assets under construction, years of additionsOur threshold 2 years of additions–0.080.020.060.10
Effective tax ratePublished threshold 17.16 per cent19.69−6.2410.7118.0320.24
Tax charged less tax paid, % of profitOur threshold 10 percentage points−8.76−35.78−29.08−6.64−6.67
A threshold marked as ours has no published figure; it is the line we read the check against.